Global Benefit of SGLT2 Inhibitors in Heart Failure With Reduced Ejection Fraction

By sjmartinez • April 30, 2023

Brownell NK, Ziaeian B, Fonarow GC. Global Benefit of SGLT2 Inhibitors in Heart Failure With Reduced Ejection Fraction. JACC Asia. 2022 Apr 19;2(2):154-156. doi: 10.1016/j.jacasi.2022.03.002. PMID: 36339123; PMCID: PMC9627794.

Tags: Asia, Cardiology/Epi, ejection fraction, heart failure, Publications, SGLT2 inhibitor

New-Onset Atrial Fibrillation as a Predictor of Cancer: Insights from a Real-World Dataset

Alzahrani A, Gokul K, Paleri A, Powers EM, Bailin S, Yang EH, Fradley M, Farjo P, Dominic P. New-Onset Atrial Fibrillation as a Predictor of[...]

The REgistry of Flow and Perfusion Imaging for Artificial Intelligence with positron emission tomography (REFINE PET):Rationale and design

Ramirez G, Lemley M, Shanbhag A, Kwiecinski J, Miller RJH, Kavanagh PB, Liang JX, Dey D, Slipczuk L, Travin MI, Alexanderson E, Carvajal-Juarez I, Packard[...]

Left Ventricular Health and TAVR Timing in Asymptomatic Severe Aortic Stenosis: Analysis From the EARLY TAVR Trial

Lindman BR, Pibarot P, Schwartz A, Cohen DJ, Giustino G, Oldemeyer JB, Strote JA, Babaliaros V, Devireddy CM, Fearon WF, Fischbein MP, Daniels D, Spies[...]